Description
Overview
Meetings By Mail 52nd Annual Nuclear Medicine & Molecular Imaging Update 2024 delivers a comprehensive update on the latest advances in nuclear medicine and molecular imaging. This on-demand course presents 19 videos totaling 4 GB, covering the impact of radiopharmaceuticals across cardiology, oncology, neurology, and more. It reflects the content originally presented at the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging’s 52nd Annual Conference, emphasizing practical imaging tools, dosimetry, and emerging procedures.
On-demand nuclear medicine education — accessible anytime, anywhere.
Format: 19 videos
Total size: 4 GB
Agenda
This course includes presentations by internationally recognized faculty on current trends and procedures in nuclear medicine and molecular imaging. Topics are organized into sessions addressing clinical applications, dosimetry, oncologic imaging, radiation safety, and future innovations.
- Developing a PET-CT RB-82 Myocardial Imaging Program
- Molecular Imaging With PET to Detect and Quantify Atherosclerotic Plaques
- RB-82 PET Myocardial Blood Flow Imaging
- Advanced Dosimetry Including Use in the Theranostics Routine
- Dosimetry Basics
- Personalized Dosimetry for Y90 TARE
- Can Radiotracer Based Bone Scanning to Detect Metastasis Survive the Test of Time
- Lymphoma Staging and Response Assessment: Past, Present and Future
- PET CT in Brain Tumors: Current and Potential Future Applications
- Recent Developments and Issues in Differentiated Thyroid Cancer
- Systemic Therapy in Advanced Prostate Cancer: The Evolving Landscape
- Benefits of SPECT-CT
- Our Quest for Ultra Low Dose PET-CT Scanning: Experience and Implications
- Panel Discussion (Radiation Safety & SPECT-CT)
- Radiation Safety in the Age of Theranostics
- Current and Emerging Radiopharmaceuticals in Theranostics
- Expanding the Practice of Lu177 Based Radiopharmaceutical Therapies From a Tertiary Care Hospital to the Community: Opportunities and Challenges
- Hype, Reality, and the Future Potential of AI in Nuclear Medicine
- PET Imaging’s Impact on Medicine, Research and Future Options
Speakers
This update features fourteen internationally renowned faculty experts contributing their latest insights on nuclear medicine and molecular imaging. The course reflects a collective expert perspective without listing individual speaker details.
Target Audience
This education is designed for nuclear medicine physicians, technologists, radiologists, neurologists, oncologists, cardiologists, endocrinologists, rheumatologists, and other medical professionals involved in the use of radionuclides in patient care. The course offers a detailed refresher on emerging techniques, applications, and safety considerations within nuclear medicine.
Why This Topic Matters
Meetings By Mail 52nd Annual Nuclear Medicine & Molecular Imaging Update 2024 provides essential knowledge to support professionals in the nuclear medicine specialty. It enhances understanding of current trends and clinical applications important for accurate diagnosis and treatment planning.
This update, made available through MedHub Central, reinforces expertise in molecular imaging and the expanding role of radiopharmaceuticals, supporting informed clinical decision-making and ongoing professional development.
